Save your place

Sign in to WhoBought

Please try again later.

Lexicon Pharmaceuticals, Inc. (LXRX) institutional ownership

Latest close $2.38 Jul 21, 2026
Market cap$389M 52-week range SectorHealthcare
Funds holding · Q1 2026
109
reported LXRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
68 buyers · 41 sellers

Lexicon Pharmaceuticals, Inc. (LXRX) price and institutional activity

Dates

Q1 2026

$0 bought by 68 investors
Artal Group S.A.Sessa Capital Im, L.P. +66 more
$0 sold by 41 investors
Citadel Advisors LLCCIBC Bancorp USA Inc. +39 more
Bought Sold Totals per quarter; hover a bar for the names.

Lexicon Pharmaceuticals, Inc. (LXRX) institutional activity · 109

Investor Type Est. change Change Δ Own Date
Artal Group S.A. · Added
Change +18.6M Date Q1 2026
Artal Group S.A. Added· Q1 2026 +18.6M Q1 2026
Sessa Capital Im, L.P. · Added
Change +14.9M Date Q1 2026
Sessa Capital Im, L.P. Added· Q1 2026 +14.9M Q1 2026
Point72 Asset Management, L.P. · Added
Change +7.5M Δ Own +2651.4% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +7.5M +2651.4% Q1 2026
FMR LLC · Added
Change +7.2M Δ Own +19.1% Date Q1 2026
FMR LLC Added· Q1 2026 +7.2M +19.1% Q1 2026
Siren, L.L.C. · Added
Change +5.4M Date Q1 2026
Siren, L.L.C. Added· Q1 2026 +5.4M Q1 2026
Vanguard · Added
Change +1.9M Date Q1 2026
Vanguard Added· Q1 2026 +1.9M Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +1.3M +508.0% Q1 2026
Marshall Wace, LLP · Added
Change +1.1M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +1.1M Q1 2026
Jane Street Group, LLC · Added
Change +942K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +942K Q1 2026
Susquehanna International Group, LLP · Added
Change +914K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +914K Q1 2026
Mackenzie Financial Corp · New
Change +773K Date Q1 2026
Mackenzie Financial Corp New· Q1 2026 +773K Q1 2026
Adar1 Capital Management, LLC · New
Change +750K Date Q1 2026
Adar1 Capital Management, LLC New· Q1 2026 +750K Q1 2026
Geode · Added
Change +669K Date Q1 2026
Geode Added· Q1 2026 +669K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −616K −36.0% Q1 2026
CIBC Bancorp USA Inc. · Reduced
Change −600K Date Q1 2026
CIBC Bancorp USA Inc. Reduced· Q1 2026 −600K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 109

Famous investor activity in Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals, Inc. (LXRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Swain Judith L. · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Swain Judith L. Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Sullivan Diane E. · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Sullivan Diane E. Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Sobecki Christopher J. · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Sobecki Christopher J. Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Cheung Ivan · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Cheung Ivan Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Barker Sam L. · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Barker Sam L. Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Amouyal Philippe · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Amouyal Philippe Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Debbane Raymond · Director 2 operations 0
Owned 0 Trade date Jun 3, 2026 Filed date Jun 4, 2026
Debbane Raymond Director 2 operations 0 0 Jun 3, 2026 Jun 4, 2026
Amouyal Philippe · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Amouyal Philippe Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Sobecki Christopher J. · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Sobecki Christopher J. Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Barker Sam L. · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Barker Sam L. Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Cheung Ivan · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Cheung Ivan Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Swain Judith L. · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Swain Judith L. Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Sullivan Diane E. · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Sullivan Diane E. Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Debbane Raymond · Director 2 operations 79K
Owned 43K Trade date May 1, 2026 Filed date May 4, 2026
Debbane Raymond Director 2 operations 79K 43K May 1, 2026 May 4, 2026
Artal Participations S.A R.l. · Director 2 operations 20.0M
Owned 0 Trade date Apr 30, 2026 Filed date May 8, 2026
Artal Participations S.A R.l. Director 2 operations 20.0M 0 Apr 30, 2026 May 8, 2026
15 of 50
15 of 50 Sign in to continue to older insider transactions.

Lexicon Pharmaceuticals, Inc. (LXRX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 38.1M
% of shares outstanding 10.5% Filing date Jul 8, 2025
FMR LLC 38.1M 10.5% Jul 8, 2025
Biotechnology Value Fund L P 12.6M
% of shares outstanding 5.1% Filing date Feb 14, 2024
Biotechnology Value Fund L P 12.6M 5.1% Feb 14, 2024
2 of 2

Lexicon Pharmaceuticals, Inc. (LXRX) ownership FAQ

Who owns LXRX?

109 reporting institutions disclosed LXRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.